Residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer: locations undetected by endoscopic biopsies in the preSANO trialBerend J. van der Wilk, J.J.B. van Lanschot, Manon C.W. Spaander et al.|British journal of surgery|2020Cited by 20
O200 10-YEAR FOLLOW-UP OF A RANDOMISED CONTROLLED TRIAL COMPARING NEOADJUVANT CHEMORADIOTHERAPY PLUS SURGERY VERSUS SURGERY ALONE FOR OESOPHAGEAL OR JUNCTIONAL CANCER (CROSS)Ben M. Eyck, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof et al.|Diseases of the Esophagus|2019Cited by 0